David Henry Mack - 08 Mar 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Issuer symbol
PMVP
Transactions as of
08 Mar 2022
Net transactions value
+$27,400
Form type
4
Filing time
09 Mar 2022, 15:33:25 UTC
Previous filing
28 Feb 2022
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $27,400 +20,000 +74% $1.37* 46,970 08 Mar 2022 Direct
transaction PMVP Common Stock Gift $0 -40,000 -21% $0.000000 147,915 09 Mar 2021 See footnote F1
transaction PMVP Common Stock Gift $0 +40,000 +100% $0.000000 80,000 09 Mar 2021 See footnote F2
holding PMVP Common Stock 56,978 08 Mar 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -20,000 -8.3% $0.000000 220,644 08 Mar 2022 Common Stock 20,000 $1.37 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2 The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4 The shares subject to the option are fully vested and immediately exercisable.